Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil vs Diltiazem for Bleeding in FESS
NCT04790331Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Mar 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of verapamil and diltiazem in sinusitis, sponsored by Assiut University. Primary endpoints: Heart Rate and Estimated Blood Loss. Status: unknown.
02
Drugs
verapamildiltiazem
03
Conditions
sinusitis
Beyond the preview
Go deeper on NCT04790331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04790331.